Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Honghuabuji granules (also known as Fufang Honghua Buji or FHB granules) are a traditional Chinese medicine (TCM) herbal formulation used primarily for the treatment of stable vitiligo. The formulation is based on TCM principles and is believed to act by improving blood circulation and modulating immune function, although the precise mechanism of action at the molecular level remains unclear. Clinical studies have shown efficacy in long-term practice for vitiligo management[1][5][7]. The product is currently being evaluated in randomized controlled trials for its effectiveness, safety, and recurrence control in patients with stable vitiligo[1][2][8]. The main indication is stable vitiligo diagnosed according to both Western medicine and TCM criteria.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound honghuabuji granules.